No Data
No Data
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $383
Income Investing: 6 Large-Cap Stocks With Growing Dividends
Dow Drops 138 Points On Losses For Shares Of American Express, Merck
Express News | Amgen Says FDA Shifted the Pdufa Date by 3 Months to Jan 17, 2025 to Allow Additional Time for Review of Supplemental Data Recently Submitted to Agency
Express News | Amgen Says FDA Has Extended Review Period for Lumakras in Combination With Vectibix for Treating Some Colorectal Cancer Patients
Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report
amiable Llama_6295 : hippee hippee